Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 96.23M
December 31, 2024 237.96M
December 31, 2023 170.03M
December 31, 2022 138.36M
December 31, 2021 86.74M
December 31, 2020 152.28M
December 31, 2019 271.66M
December 31, 2018 160.05M
December 31, 2017 310.79M
December 31, 2016 346.50M
December 31, 2015 521.35M
December 31, 2014 339.34M
December 31, 2013 129.13M
December 31, 2012 223.21M
December 31, 2011 281.69M
Date Value
December 31, 2010 211.11M
December 31, 2009 162.51M
December 31, 2008 103.11M
December 31, 2007 258.78M
December 31, 2006 80.00M
December 31, 2005 99.70M
December 31, 2004 87.56M
December 31, 2003 161.00M
December 31, 2002 123.10M
December 31, 2001 156.44M
December 31, 2000 202.68M
December 31, 1999 212.76M
December 31, 1998 19.42M
December 31, 1997 1.98M
December 31, 1996 0.00

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Viatris, Inc. 1.454B
Pfizer Inc. 13.60B
ANI Pharmaceuticals, Inc. 294.75M
Corcept Therapeutics, Inc. 372.15M
Veru, Inc. 18.32M